From the aerial part of Barleria lupulina, 8-O-acetyl-6-O-trans-p-coumaroylshanzhiside, saletpangponosides A-C and 8-O-acetylmussaenoside were isolated together with 13 known compounds. The structural elucidations were based on analyses of physical and spectroscopic data. #
Introduction
As part of our ongoing study on Thai medicinal plants, we investigated the constituents of Barleria lupulina Lindl. (Acanthaceae, Thai name: Sa-let-pangpon, Chong-ra-ar) collected in the Botanical gardens, Faculty of Pharmaceutical Sciences, Khon Kaen University, Thailand. B. lupulina is a small shrub, distributed in the South-east Asia region. In Thai traditional medicine, the plant is externally used as an antiinflammatory for insect bite, herpes simplex and herpes zoster. In preliminary investigations nine iridoid glucosides (Suksamrarn 1986; Byrne et al., 1987; Tuntiwachwuttikul et al., 1998) have been isolated. In addition, some anti-HSV-2 (herpes simplex virus type 2) activity of organic extracts of the plant have been reported (Yoosook et al., 1999) . The present study deals with the isolation and structure elucidation of iridoid glucosides (1-12), of which five are new (5) (6) (7) (8) 12) , together with six other known compounds; phenylpropanoid glycosides (13-15), lignan glucoside (16), aliphatic glycoside (17) and benzyl alcohol glycoside (18) from the aerial part of this plant.
Results and discussion
The methanolic extract of the aerial part of B. lupulina was suspended in H 2 O and defatted with Et 2 O. The aqueous layer was subjected to column chromatography using a highly porous copolymer of styrene and divinylbenzene, and eluted with H 2 O, MeOH and Me 2 CO, successively. The fraction eluted with MeOH was repeatedly subjected to column chromatography using silica gel and octadecylsilyl silica gel, then by preparative HPLC-ODS to afford 18 compounds (1-18). Thirteen were known compounds; shanzhiside methyl ester (1), 8-O-acetylshanzhiside methyl ester (barlerin) (2), 6-O-acetylshanzhiside methyl ester (3), 6,8-O,Odiacetylshanzhiside methyl ester (acetylbarlerin) (4) (Damtoft et al., 1982; Byrne et al., 1987) , ipolamiide (9) (Damtoft et al., 1984b) , ipolamiidoside (10) (Byrne et al., 1987) , phlorigidoside B (11) , forsythoside B (13) (Endo et al., 1982) , verbascoside (14) (Andary et al., 1982) , poliumoside (15) (Andary et al., 1985) , (+)-lyoniresinol 3a-O-b-glucopyranoside (16) (Achenbach et al., 1992) , (3R)-1-octen-3-yl-b-primeveroside (17) (Yamamura et al., 1998) and benzyl alcohol b-(2 0 -O-b-xylopyranosyl) glucopyranoside (18) (Sudo et al., 2000) by physical data and spectroscopic evidences.
The molecular formula of compound 5 was determined as C 27 H 32 O 14 by HR-FAB mass spectrometry. Inspection of the 13 C NMR spectral data revealed the 0031-9422/01/$ -see front matter # 2001 Elsevier Science Ltd. All rights reserved. P I I : S 0 0 3 1 -9 4 2 2 ( 0 1 ) 0 0 2 3 6 -9 (Tuntiwachwuttikul et al., 1998) , except for lacking the methoxy signal due to the carbomethoxy group, which established the presence of a carboxyl group. On the basis of these spectral data, the structure of compound 5 was determined as 8-O-acetyl-6-O-trans-p-coumaroylshanzhiside.
The molecular formula of compound 6 was determined as C 34 H 44 O 19 by HR-FAB mass spectrometry. The 1 H and 13 C NMR spectral data showed the presence of two b-glucopyranosyl units, one trans-coumaroyl moiety, as well as the signals for an acetyl group and a carbomethoxy group. The 1 H and 13 C NMR spectra were very similar to those of 8-O-acetyl-6-O-trans-pcoumaroylshanzhiside methyl ester (Tuntiwachwuttikul et al., 1998) , except for a set of additional signals arising from a b-glucopyranosyl moiety in 6. The additional glucopyranosyl unit was assigned to be attached at C-4 00 (d 160.9) of the coumaroyl moiety because the chemical shifts of C-4 00 , C-3 00 ,5 00 ( 118.0) changed by +0.2 and-2.6 ppm, respectively. Moreover, the HMBC spectrum provided further confirmation with a significant correlation between H-1 000 (d 4.93, d, J=7.6 Hz) of this glucopyranosyl unit and C-4 00 of the coumaroyl moiety. Consequently, the structure of compound 6 was assigned as 6-O-(4
The molecular formula of compound 7 had the same elemental composition as 6, C 34 H 44 O 19 , by HR-FAB mass spectrometry. The 1 H and 13 C NMR spectral data were very similar to those of 6. The only significant difference was the coupling constants of the olefinic protons ( 5.86 and 6.94, J=12.9 Hz). Therefore, the structure of compound 7 was determined as the cis isomer of 6, named saletpangponoside B.
The molecular formula of compound 8 was determined as C 26 H 34 O 13 by HR-FAB mass spectrometry. The 1 H and 13 C NMR spectral data indicated that 8 is a derivative of shanzhiside methyl ester (1), with an ester moiety on the 8-hydroxy group because of the downfield shift of C-8 (+10.5 ppm). The ester moiety showed the presence of an AA 0 BB 0 system ( 6.64 and 6.98, J=8.6 Hz from 1 H NMR), two methylenes ( 2.49 and 2.76 from 1 H NMR, and 38.2 and 31.2 from 13 C NMR) and a carbonyl carbon ( 175.0), identified as a p-dihydrocoumaroyl moiety. The complete assignments were confirmed by the HMBC spectrum, in which H-a ( 2.49) showed a three bond correlation to C-1 00 ( 132.6), and H-b (d 2.76) showed the significant correlation to C-2 00 ,6 00 ( 130.3). Thus, the structure of compound 8 was elucidated as 8-O-p-dihydrocoumaroylshanzhiside methyl ester, named saletpangponoside C. The molecular formula of compound 12 was determined as C 19 H 28 O 11 by HR-FAB mass spectrometry. The 1 H and 13 C NMR spectra indicated an iridoid structure. The chemical shifts were very similar to those of mussaenoside (Damtoft et al., 1984a) except that the acetyl group was observed in the spectra. The attachment of the acetyl group was assigned to C-8 ( 91.0), the carbon signal of which was shift to downfield by 10.6 ppm. Therefore, the structure of compound 12 was identified as 8-O-acetylmussaenoside.
Experimental

General
NMR spectra were recorded in CD 3 OD using a JEOL JNM A-400 spectrometer ( 
Extraction and isolation
The dried aerial part (900 g) of B. lupulina was extracted with hot MeOH. After removal of the solvent by evaporation, the residue (100 g) was defatted with Et 2 O. The aqueous layer was subjected to a column of highly porous copolymer of styrene and divinylbenzene and eluted with H 2 O, MeOH and Me 2 CO, successively. The fraction eluted with MeOH (29.0 g) was subjected to a column of silica gel (systems I, II and III, respectively) affording five fractions. Fraction 2 (7.4 g) was applied to a RP-18 column using system IV to provide six fractions, together with compound 4 (5.1 g). Fractions 2-5 were purified by prep. HPLC-ODS (system VI) to afford compounds 8 (43 mg) and 12 (27 mg). Fraction 3 (8.4 g) was subjected to a column of RP-18 (system IV) to give eight fractions, along with compounds 2 (2.6 g) and 10 (596 mg). Fractions 3-1 and 3-2 were further purified by prep. HPLC-ODS (system V) to provide compound 3 (398 mg). Fraction 3-8 was purified by prep. HPLC-ODS (system VI) to afford compound 16 (92 mg). Fraction 4 (8.2 g) was applied to a RP-18 column (system VII) to afford fifteen fractions, and compound 1 (1.9 g). Fraction 4-5 was purified by prep. HPLC-ODS (system VIII) to give compounds 9 (50 mg) and 18 (59 mg). Fraction 4-8 was purified by prep. HPLC-ODS (system V) to provide compounds 11 (32 mg) and 17 (27 mg). Fraction 4-9 was further purified by prep. HPLC-ODS (system IX) to give compounds 13 (162 mg), 14 (73 mg) and 15 (138 mg). Finally, fractions 4-13 and 4-14 were purified by prep. HPLC-ODS (system VI) to provide compound 5 (23 mg), 6 (90 mg) and 7 (73 mg). 
8-O-
